GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Deferred Policy Acquisition Costs

Autobio Diagnostics Co (SHSE:603658) Deferred Policy Acquisition Costs


View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Autobio Diagnostics Co (SHSE:603658) Business Description

Traded in Other Exchanges
N/A
Address
No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.
Executives
Miao Yong Jun Director